The Center For Disease Dynamics, Economics & Policy

Background

Antimicrobial drug resistance (AMR) poses a significant public health challenge, threatening the ability to cure many common infectious diseases. Across Africa, AMR is a documented challenge for many bacterial infections, particularly those associated with healthcare.

 

The misuse and overuse of antimicrobials in the human health sector is a major driver of AMR globally. The development and implementation of standard treatment guidelines (STGs), particularly when informed by local data, offer one of several opportunities to reduce the misuse and overuse of antimicrobials.